The Federal Reserve, along with the other U.S. banking agencies, has made substantial progress in building stronger regulatory and supervisory programs since the global financial crisis.
Quarles highlights progress in financial regulation since the crisis.
Share
More from Ryan F. Quarles
The FDA needs to provide regulatory pathways for products containing CBD. The FDA needs to act now.
Similarly, that has always been a high priority of the Federal Reserve, and where we have the enforcement authority to act, we will do that.
It is not our intention. Indeed, it is the opposite of our intention, to affect the total loss-absorbing capacity of the largest firms.